loader
Please Wait
Applying Filters...

Seqens Seqens

X

Melinta Therapeutics's list of EU CTD Dossiers, Marketing Authorizations, In, Out Licensing Opportunities & Finished Dosage Formulations aggregated by PharmaCompass

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 DELAFLOXACIN MEGLUMINE (2)

02 ORITAVANCIN DIPHOSPHATE (2)

filter

01 MELINTA (2)

02 MELINTA THERAP (2)

filter

01 POWDER;INTRAVENOUS (3)

02 TABLET;ORAL (1)

filter

01 EQ 1.2GM BASE/VIAL (1)

02 EQ 300MG BASE/VIAL (1)

03 EQ 400MG BASE/VIAL (1)

04 EQ 450MG BASE (1)

filter

01 USA (4)

URL Supplier Web Content
TABLET;ORAL
EQ 450MG BASE
BAXDELA
USA
208610
2017-06-19
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
POWDER;INTRAVENOUS
EQ 300MG BASE/VIAL
BAXDELA
USA
208611
2017-06-19
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
POWDER;INTRAVENOUS
EQ 400MG BASE/VIAL
ORBACTIV
USA
206334
2014-08-06
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
POWDER;INTRAVENOUS
EQ 1.2GM BASE/VIAL
KIMYRSA
USA
214155
2021-03-12
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY